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Background: The best approach to the management of concomitant severe carotid and coronary artery disease remains uncertain to date. We 
evaluated short- and long-term outcomes of three strategies: Staged carotid endarterectomy (CEA) or carotid artery stenting (CAS) followed by open 
heart surgery (OHS) or combined CEA and OHS.
Methods: From 1997 to 2009, 327 patients underwent carotid revascularization either as staged endarterectomy (n=64) or stenting (n=96) within 
90 days prior to OHS or combined CEA-OHS (n=167). CAS-OHS patients had a higher prevalence of prior stroke (p = 0.012) and prior CEA (p = 
0.0007) than CEA-OHS patients. The primary end point was all-cause mortality; secondary end points were myocardial infarction (MI), stroke, and a 
composite of death, MI and stroke. Outcomes were compared using Cox proportional hazards multivariable time to event analysis.
Results: Table 1 illustrates the adjusted hazard ratios for the primary and secondary end points. CAS-OHS had the lowest mortality. Myocardial 
infarction occurred more frequently after staged CEA-OHS (unadjusted P[log rank] < 0.0001), with similar rates of stroke among all three groups 
(unadjusted P[log rank] = 0.23).
Conclusion: Carotid artery stenting followed by OHS is a less invasive alternative to either staged CEA-OHS or combined CEA-OHS with no 
significant increased risk of long term death, MI or stroke, even in a neurologically high risk population.
Table 1: Comparison of cohorts for the primary and secondary end points 
Cohort Adjusted Hazard Ratio 95% Confidence interval P value
Primary end point (all-cause mortality)
CAS-OHS vs combined CEA-OHS 0.57 (0.54, 0.95) 0.031
CAS-OHS vs staged CEA-OHS 1.02 (0.54, 1.53) 0.96
Staged CEA-OHS vs combined CEA-OHS 0.56 (0.31, 0.99) 0.049
Secondary composite end point (death, MI and stroke)
CAS-OHS vs combined CEA-OHS 1.14 (0.76, 1.71) 0.52
CAS-OHS vs staged CEA-OHS 0.58 (0.54, 0.92) 0.019
Staged CEA-OHS vs combined CEA-OHS 1.97 (1.34, 2.90) 0.0005
